Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grove Street, formerly known as Grove Street Advisors, is a specialized private equity investment firm that manages customized portfolios for institutional investors. The firm acts as a "gatekeeper" or fund-of-funds manager, focusing heavily on the venture capital and private equity sectors, with a significant portion of its capital allocated to the life sciences and biotechnology industries. By investing in top-tier venture capital funds such as ARCH Venture Partners, Flagship Pioneering, and Third Rock Ventures, Grove Street plays a critical role in the financing ecosystem of early-stage drug development and healthcare technology. The firm is headquartered in Wellesley, Massachusetts, and is recognized for its deep expertise in identifying and accessing high-performing investment opportunities within the global innovation economy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grove Street Advisors.